CLEW

Company Overview

Snapshot

Founded in December 2014 by Gal Salomon and Avigdor Faians, CLEW operates with 11–50 employees. The company has raised a total of $20.5 million across six funding rounds from five investors.

Business overview

CLEW develops patient-level physiological predictive models using artificial intelligence and data science. Initially proven in intensive care units (ICUs), these models are now expanding to all care settings to assist healthcare providers in forecasting patient states. Deployable from the bedside to centralized command-and-control facilities, CLEW's technology aims to enhance clinical decision-making, improve patient outcomes and safety, streamline care, and reduce costs. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Medical Decision Support, serving healthcare providers in markets such as the United States, Europe, and Israel.

Strategic signal

In April 2024, CLEW expanded its intelligent clinical surveillance platform to all inpatient settings, following a new study that found its AI-driven prediction models accurately predict critical care patient deterioration and significantly reduce false alarms. This expansion signals a strategic move to broaden the application of its core technology beyond ICUs, demonstrating the platform's versatility and potential for wider adoption across healthcare facilities, which could drive substantial growth and market penetration.

Company Intelligence Q&A

What is CLEW's core technology?

CLEW utilizes artificial intelligence and data science to develop patient-level physiological predictive models, initially for intensive care units and now expanding to all care settings.

When did CLEW receive FDA clearance for its AI-based predictive analytics?

CLEW Medical received FDA clearance for its AI-based predictive analytics technology to support adult ICU patient assessment in February 2021.

What was a significant recent partnership for CLEW?

In June 2024, AvaSure teamed up with CLEW Medical to boost high-acuity care with AI-driven virtual surveillance, indicating a strategic collaboration to enhance critical care capabilities.

What was a recent product launch by CLEW?

In March 2025, CLEW announced the launch of its Sepsis Virtual Unit (SVU), designed to enhance SEP-1 compliance and improve patient outcomes.

Who was recently appointed as CLEW's CEO?

In November 2022, CLEW announced the appointment of Paul Roscoe as its new CEO.